Bernadette Connaughton
Directeur/Membre du Conseil chez HALOZYME THERAPEUTICS, INC.
Fortune : 4 M $ au 30/06/2024
Profil
Bernadette Mary Connaughton currently works at Halozyme Therapeutics, Inc., as Independent Director from 2018, Zealand Pharma A, as Independent Director from 2019, Editas Medicine, Inc., as Independent Director from 2021, and Boys & Girls Clubs of New Jersey, as Trustee.
Ms. Connaughton also formerly worked at Visterra, Inc., as Director from 2015 to 2018, Syneos Health, Inc., as Independent Director from 2019 to 2023, Bristol Myers Squibb Co., as Head-European Markets, Canada & Australia from 2014 to 2017, and Bristol-Myers Squibb Pharma Co., as President-China, Latin America & Middle East from 2004 to 2017.
Ms. Connaughton received her undergraduate degree from The Johns Hopkins University and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 25/04/2024 | 46 787 ( 0,04% ) | 2 M $ | 30/06/2024 | |
ZEALAND PHARMA A/S
0,01% | 31/12/2023 | 8 500 ( 0,01% ) | 1 M $ | 30/06/2024 |
EDITAS MEDICINE, INC.
-.--% | 30/05/2024 | 0 ( -.--% ) | - $ | 30/06/2024 |
Postes actifs de Bernadette Connaughton
| Sociétés | Poste | Début |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Directeur/Membre du Conseil | 10/09/2018 |
| ZEALAND PHARMA A/S | Directeur/Membre du Conseil | 04/04/2019 |
| EDITAS MEDICINE, INC. | Directeur/Membre du Conseil | 26/10/2021 |
| Boys & Girls Clubs of New Jersey | Directeur/Membre du Conseil | - |
Anciens postes connus de Bernadette Connaughton
| Sociétés | Poste | Fin |
|---|---|---|
| SYNEOS HEALTH, INC. | Directeur/Membre du Conseil | 28/09/2023 |
| VISTERRA INC | Directeur/Membre du Conseil | 01/08/2018 |
| Bristol-Myers Squibb Pharma Co. | Corporate Officer/Principal | 01/10/2017 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2017 |
Formation de Bernadette Connaughton
| The Johns Hopkins University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| ZEALAND PHARMA A/S | Health Technology |
| EDITAS MEDICINE, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Visterra, Inc.
 Visterra, Inc. Pharmaceuticals: MajorHealth Technology Visterra, Inc. Is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of antibody-based therapies for kidney diseases, and other chronic diseases. It focuses on its research technology platform, HIEROTOPE technology. The company was founded by Alan L. Crane, Kevin J. Bitterman and Ram Sasisekharan on December 20, 2007 and is headquartered in Waltham, MA. | Health Technology |
Syneos Health, Inc.
 Syneos Health, Inc. BiotechnologyHealth Technology Syneos Health, Inc. engages in the provision of biopharmaceutical solutions. It operates through the Clinical Solutions and Commercial Solutions segments. The Clinical Solutions segment offers global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development. It also offers individual services including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, and consultancy services. The company was founded in 1998 and is headquartered in Morrisville, NC. | Health Technology |
| Boys & Girls Clubs of New Jersey | |
| Bristol-Myers Squibb Pharma Co. |
